2011 Business Outlook Survey : Community and hospital pharmacists prepare to steer their course An update on Clostridium difficile infection Counterfeit drug war continues When does compounding become manufacturing? Study : Post-MI beta blocker doses are too low
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.